The Nasdaq‑100 is showing a repeat of a historic pattern where the index climbs while fewer components stay above their 200‑day moving average, a signal that preceded >20% corrections in 2021 and 2024. The metric has again slipped, and the index is now about 6% below its all‑time high, with technology—the sector that fuels the Nasdaq—underperforming the broader market. Analysts warn that this divergence could trigger another 20% pullback, especially as risk‑off sentiment spreads across equities and crypto. The piece also highlights AI‑driven growth expectations centered on Nvidia, underscoring concentration risk.
The Invesco Russell 1000 Equal Weight ETF (EQAL) has outperformed peers IVV and IWB this year thanks to its equal‑weight tilt amid a capital‑rotation environment. However, its longer‑term track record remains weak, having lagged IVV, IWB, RSP, and EQL since 2014....
Los Angeles‑based Scopely agreed to acquire a majority stake in Istanbul‑born mobile‑game studio Loom Games, valuing the company at over $1 billion through a performance‑based structure. Loom, founded in August 2025, launched its first title “Pixel Flow” in September, attracting more than 10 million...

What happened to the stock market? The market rally has come to a HALT. Earnings and innovation are not the problem, liquidity is.

All eyes on $NVDA heading into tomorrow which technically DID make its highest close of 2026 today, but yet could face some headwinds from a cycle composite which is "not too bullish" starting next month https://t.co/XW54gpjWXm Important to keep a close eye...
The Australian government is closely tracking new iron‑ore pricing arrangements being trialled between Chinese buyers and major Australian producers. Companies such as Fortescue and Rio Tinto have begun using Fastmarkets, while BHP negotiates with China Mineral Resources Group over alternative...

Wednesdays watchlist is going up soon - Did you catch today’s top stock? #howtotrade #stockstowatch #daytrading #momentum #tradingeducation

Spicerhaart’s haart Partnership Scheme is expanding nationally, backed by agents who cite increased autonomy, profitability and work‑life balance. Testimonials from Jack Pollock, Roger Jackson and Janette Churchill illustrate how the model blends self‑employment flexibility with corporate resources such as tech,...

Bangladesh’s February 12 election gave the Bangladesh Nationalist Party a decisive parliamentary super‑majority, easing short‑term political uncertainty. The win clears the path for a long‑awaited constitutional referendum that could reshape the legislature, judiciary and prime‑ministerial term limits. Fitch Ratings notes that...

The Property Solvers study reveals conveyancing fees in the UK climbing well above inflation, with freehold sale costs hitting £1,317 in 2026—a 10.6% rise year‑on‑year. Leasehold and remortgage fees also posted double‑digit increases, outpacing the 3% CPI. Regulatory, AML, and...
Panama's government announced the seizure of two strategic ports along the Panama Canal, citing national security and revenue concerns. The move follows a series of regulatory actions aimed at tightening state control over critical infrastructure. Officials indicated that the ports...

MarketSmith India released its top stock picks for 25 February as Indian equities slumped. The Nifty 50 dropped 1.12% to 25,424.65 and the Sensex fell 1.28%, driven by a 4.74% plunge in the IT index. AI‑related disruption fears after Anthropic’s new tools,...

Hong Kong’s Financial Secretary Paul Chan announced a 2026 GDP growth projection of 2.5%‑3.5%, raising expectations beyond the 2%‑3% range slated for 2025. The forecast follows a 3.5% expansion in 2025, the strongest pace since 2021, underscoring a robust post‑pandemic...

That time during the GFC when you went to buy U.S. real estate, found thousands of listings in a few zip codes with asking prices from $15k CAD to $60k CAD, and Canadians real estate “experts” told you that it...
Argentina’s Vaca Muerta looks great on paper, but it’s not the next Permian. Argentina’s fiscal mess, weak infrastructure, & massive capex needs are real barriers. Continental’s hype says as much about a fading Bakken play as it does about Vaca Muerta. https://t.co/SGzycaNHEd #Oil...
The Acquirer’s Multiple® Large‑Cap screen highlights a persistent valuation gap where capital‑intensive cyclicals, commodity‑linked firms, and financials trade at deep discounts despite solid operating income and free‑cash‑flow generation. Energy giants like Equinor and Petrobras, steel producer ArcelorMittal, and banks such...

South Korea's KOSPI index surged past the 6,000 mark, closing at a record 6,085 on Wednesday. The rally was powered by a sharp rise in global memory demand, lifting Samsung Electronics 2.5% and SK Hynix 2.1%. The benchmark is now...
I've been a financial consultant to millionaires in Singapore and across Southeast Asia for nearly a decade. Here's what I've learned: the most painful financial conversations happen after someone passes away. The ones that could have been prevented by a single...

If you want a deal in 30 days, master these five things: finding sellers, negotiating contracts, finding buyers, raising capital, and managing construction. Learn the skills, get paid.
Solar’s Invesco Solar ETF (TAN) has surged over 23% year‑to‑date through Feb 24, 2026, far outpacing the S&P 500’s modest 0.8% gain. The U.S. Energy Information Administration projects a record 86 GW of utility‑scale capacity additions in 2026, with solar comprising 51% of...
Well, the WSJ oped page lost me with statement that the balance of payments is a non issue ... 1/2
Foreign stocks are beating US stocks and the dollar is weakening, yet foreigners bought $1.4 trillion in US securities last year. The selling wave everyone is talking about isn't showing up in the data. 🔒 Members-Only https://t.co/yXliX9IMIO

UK homeowners have amassed roughly £677 bn of equity since the 2008 crisis, driving the average loan‑to‑value ratio down to 59%, well below the 70% peak in 2012. By 2024, only 42% of private homes retain a mortgage, indicating a shift...

Don’t waste your time adding AI wrappers to free earnings data. The edge is in price. The Daily Beat’s proprietary Reaction Score tracks expectations vs the move so the winners show up on the scoreboard. Grateful for tools that keep...
Buying and selling feel easier than holding because we are wired to believe activity = productivity. Holding is hard because it feels like inaction and complacency. But every day holding is an active decision.

Wall Street’s recent AI anxiety sparked a sharp selloff in software stocks, pushing many private tech firms to postpone IPOs as investors anticipate a handful of mega‑offerings to dominate the market. A viral Citrini Research report amplified fears, warning that...
Stocks & the dollar hang in the balance amid tariff chaos and possible war with Iran as President Trump delivers his State of the Union speech. Are the markets in trouble? #SOTU2026 #Trump #tariffs #Iran #market #stockmarkets #DOLLAR #Macro #Trading https://t.co/PVSRBaRIjl

Don't like the Yomeishu Seizo takeover at ¥4,050/share? I wrote 4-Jan-26 this wasn't worth owning. It was Murakami-owned (Yuzawa is Murakami (see 2nd pic)) and he would act in his own interest, and therefore ¥4,021 was a floor price. I...
Core Laboratories reported Q4 2025 revenue of $138.3 million, up 3% sequentially and 7% year‑over‑year, driven by stronger international demand for reservoir description services. The Reservoir Description segment posted $92.3 million in revenue with a 14% operating margin, while Production Enhancement revenue...
No reason to own healthcare outright. Such a bifurcated sector of the market. $IHE > $IHF

Migration patterns for the Chicago MSA in the past few years really illustrate what I've called "The Great Stay." Q2 2025 was the first period in many years where inbound migration exceeded outbound migration. Over the last 8 years, total moves...
Ibotta reported Q4 2025 revenue of $83.3 million, a 16% year‑over‑year decline, and non‑GAAP gross margin of 80%, down roughly 800 basis points. The company highlighted strong traction for its LiveLift pilots, with an 83% re‑up rate, and announced a...
Mirum Pharmaceuticals reported $521 million in 2025 net product sales, a 55% year‑over‑year increase driven by Livmarli and bile‑acid medicines, surpassing guidance. Operating expenses rose to $543 million, yet the company generated positive cash flow and ended the year with $391 million in...
Teladoc Health reported Q2 2025 revenue of $631.9 million, a modest 1.6% decline YoY, while adjusted EBITDA reached $69.3 million, hitting the high end of guidance. Integrated care drove growth, delivering $391.5 million in revenue and expanding U.S. membership to 102.4 million, surpassing 100 million members....
Astec Industries reported a strong Q4 2025, with adjusted EBITDA climbing 55.7% year‑over‑year to $27.1 million and net sales up 20.1% thanks to robust demand for asphalt and concrete plants and the TerraSource acquisition. The company’s backlog expanded to $449.5 million, including...
Montrose Environmental Group reported first‑quarter 2022 revenue of $134.7 million, a modest 0.6% year‑over‑year increase, driven by strong organic growth in its measurement‑and‑analysis and remediation segments. PFAS water‑treatment and biogas services surged, while COVID‑related CTEH revenues continued to normalize below historic...
Soleno Therapeutics reported $190.4 million in net revenue for fiscal 2025, representing less than nine months of commercial sales of its VICAT XR therapy. The company turned profitable, posting $20.9 million net income and generating $48.7 million of operating cash in Q4, ending the...
Nvidia announced a return to the consumer PC market with new low‑power system‑on‑chip devices slated for Dell, Lenovo and other OEMs. The chips combine CPU and GPU functions, aiming to extend battery life and diversify Nvidia’s revenue beyond data centers....
HNI Corp reported third‑quarter 2025 non‑GAAP EPS of $1.10, a 7% year‑over‑year increase, and posted a record non‑GAAP operating margin of 10.8%. Workplace furnishings sales rose 3% organically, with segment margin surpassing 12% after a 40‑basis‑point improvement. Management reaffirmed its...
Procept Biorobotics reported a 48% year‑over‑year revenue increase to $79.2 million in Q2 2025, driven by strong U.S. growth and a 58% surge in handpiece and consumable sales. Gross margin expanded to 65.4%, up 640 basis points, while adjusted EBITDA loss narrowed...
Revolution Medicines reported that its lead KRAS inhibitor doraxonrasib secured breakthrough therapy, orphan drug, and a FDA National Priority Voucher, underscoring its potential in pancreatic cancer. Phase I data revealed median overall survival of 13.1‑15.6 months and a 47% objective...
Agilent Technologies reported Q1 2026 core revenue of $1.8 billion, up 4.4% year‑over‑year, and non‑GAAP earnings per share of $1.36, meeting internal expectations despite a $10 million hit from a winter storm. Operating margin held at 24.6% after a 50‑basis‑point decline, while...
Nu Skin Enterprises reported FY 2025 adjusted EPS of $1.27, a 51% increase, with full‑year revenue of $1.49 billion and Q4 revenue of $370 million, both within guidance. Operating margin rose to 6.7% and cash balance reached $240 million while debt fell to...
Crescent Capital BDC reported Q4 2025 net investment income of $0.46 per share, delivering 110% coverage of its $0.42 regular dividend. Net asset value slipped to $19.28 per share, driven by $0.15 per share of unrealized losses from tariff‑impacted borrowers....
StandardAero reported a record $6.05 billion in 2025 revenue, up 15.8% year‑over‑year, driven by double‑digit organic growth across its Engine Services and Component Repair segments. Adjusted EBITDA rose 17% to $888 million and free cash flow surged to $209 million, reflecting stronger pricing,...
Schrödinger reported Q2 FY2025 revenue of $54.8 million, up 16% year‑over‑year, driven by 15% software growth to $40.5 million and 19% drug‑discovery growth to $14.2 million. Gross margin slipped to 68% as the mix shifted toward lower‑margin services and new predictive‑toxicology investments. Net...
TKO Group Holdings reported Q3 2025 revenue of $1.12 billion, a 27% decline driven by the loss of On Location Olympic revenue, while adjusted EBITDA surged 59% to $360 million, lifting the margin to 32%. The company secured a seven‑year, $7.7 billion UFC...
Sarepta Therapeutics reported a blockbuster fourth quarter, with ELEVIDYS gene‑therapy sales of $384 million, surpassing guidance by $60 million, and total net product revenue of $1.79 billion for 2024, up 56% year‑over‑year. The company achieved GAAP profitability and cash‑flow positivity, confirming the financial...
Hercules Capital reported record Q4 2025 performance, originating $1.06 billion in new debt and reaching $4 billion in annual originations while expanding platform AUM to $5.7 billion, a 20.5% increase. Total investment income rose 7.9% year‑over‑year to $532.5 million, and net investment income generated...
Insight Enterprises reported Q4 2025 revenue of $2 billion, a 1% decline driven by a 4% drop in product sales and an 18% fall in on‑prem software as customers migrate to cloud. Gross profit rose 9% to a 23.4% margin, marking...